![Tiago Girão](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Tiago Girão
Finanzdirektor/CFO bei
IMMUNOVANT, INC.
Vermögen: 10 Mio $ am 31.08.2026
Profil
Tiago M.
Girão is currently Chief Financial Officer at Proteovant Therapeutics, Inc. and will be Chief Financial Officer at Immunovant, Inc. starting in 2025.
Former positions include Independent Director at Landos Biopharma, Inc. from 2021 to 2024; International Controller at NuVasive LLC from 2012 to 2014; Senior Manager at KPMG LLP from 2000 to 2004; Chief Financial Officer & Vice President at Plus Therapeutics, Inc. from 2014 to 2015; Senior Accountant at Ernst & Young Terco; Chief Financial Officer at Roivant Sciences, Inc.; and Chief Financial Officer & Senior VP-Operations at Cytori Therapeutics, Inc. from 2014 to 2019.
Education includes an undergraduate degree from the University of Fortaleza.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IMMUNOVANT INC 0,12 % | 23.07.2026 | 240.798 ( 0,12 % ) | 10 Mio $ | 31.08.2026 |
| 25.07.2018 | 1 ( -.--% ) | 3 $ | 31.08.2026 |
Aktive Positionen von Tiago Girão
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNOVANT, INC. | Finanzdirektor/CFO | 18.04.2025 |
Proteovant Therapeutics, Inc. | Finanzdirektor/CFO | - |
Ehemalige bekannte Positionen von Tiago Girão
| Unternehmen | Position | Ende |
|---|---|---|
| LANDOS BIOPHARMA, INC. | Direktor/Vorstandsmitglied | 23.05.2024 |
| CERENOME, INC. | Finanzdirektor/CFO | 31.03.2019 |
Cytori Therapeutics, Inc.
 Cytori Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treatment and devices for cell therapy | Finanzdirektor/CFO | 01.03.2019 |
| NUVASIVE, INC. | Comptroller/Controller/Auditor | 01.08.2014 |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Corporate Officer/Principal | 01.08.2004 |
Ausbildung von Tiago Girão
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
77
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
NuVasive, Inc.
 NuVasive, Inc. Medical SpecialtiesHealth Technology Designs and develops medical devices for the surgical treatment of spine disorders | Health Technology |
KPMG LLP
KPMG LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, tax and advisory services | Commercial Services |
Plus Therapeutics, Inc.
 Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
Ernst & Young Terco
 Ernst & Young Terco Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
University of Fortaleza
 University of Fortaleza Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Landos Biopharma, Inc.
 Landos Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases | Health Technology |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Immunovant, Inc.
 Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
Cytori Therapeutics, Inc.
Cytori Therapeutics, Inc. BiotechnologyHealth Technology Engages in development of treatment and devices for cell therapy | Health Technology |
Proteovant Therapeutics, Inc. |
